Boehringer Ingelheim Animal Health USA Inc.;Genvec Inc.;The Government of the United States of America, as represented by the Secretary of Homeland Security
The present invention encompasses FMDV vaccines or compositions. The invention encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV.